Summary
Early results with ifosfamide plus mesna in soft tissue sarcoma showed an initial response rate of 38% in 42 patients. All these patients treated at The Royal Marsden Hospital plus 30 more (total 67) have now been analysed. Single doses of 5 or 8 g/m2 ifosfamide were given over 24 h by infusion in dextrose saline together with 400 mg/m2 or 600 mg/m2, respectively, of mesnum every 4 h to give a total of 9 doses. A diuresis of 200 ml/hour was maintained during therapy. Treatment was repeated 3-weekly. CR was seen in 6 and PR in 10 patients.
More recently doxorubicin was added to ifosfamide therapy in an attempt to improve on these results. At first only 20 mg/m2 doxorubicin was given but this was escalated to 40 mg/m2 and 60 mg/m2. Mesna has been given in higher dosage (5 g/m2 over 24 h), but otherwise the schedule is as above. In all 60 patients have been treated and most are now evaluable for response.
Encephalopathy has been seen with both regimens. The incidence and patient characteristics are reported.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Antman KH, Montella D, Rosenbaum C, Schwen M (1985) Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma. Cancer Treat Rep 69:499–504
Bierbaum W, Firusian N, Higi M, Niederle N, Scheulen ME, Schmidt CG, Seeber S (1981) Chemotherapeutische Behandlungsmöglichkeiten bei fortgeschrittenen Sarkomen. Dtsch Med Wochenschr 106:1181–1185
Bramwell V, Mouridsen H, Santoro A, Blackledge G, Somers R, Thomas D, Sylvester R, Bush H (1985) Cyclophosphamide (CP) vs ifosfamide (IF): A randomised phase II trial in adult soft tissue sarcoma (STS). Preliminary report of EORTC Soft Tissue and Bone Sarcoma Group. Proc Am Soc Clin Oncol 4:143
Czownicki A, Utracka-Hutka B (1977) Contribution to the treatment of malignant tumours with ifosfamide. In: Burkert H, Voigt HC (eds) Proceedings of the International Holoxan Symposium, Düsseldorf. Asta-Werke, Bielefeld, pp 109–111
De Kraker J, Voute PA (1984) Ifosfamide and vincristine in paeditric tumours. A Phase II study. Eur Paediatr Haematol Oncol 1:47–50
Meanwell CA, Blake AE, Blackledge G, Blake DR et al (1985) Encephalopathy associated with ifosphamide/mesna therapy. Lancet 1:406–407
Stuart-Harris R, Harper PG, Parsons CA, Kay SB, Mooney CA, Gowing NF, Wiltshaw E (1983) High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft tissue sarcoma. Cancer Chemother Pharmacol II:69–72
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wiltshaw, E., Westbury, G., Harmer, C. et al. Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma. Cancer Chemother. Pharmacol. 18 (Suppl 2), S10–S12 (1986). https://doi.org/10.1007/BF00647439
Issue Date:
DOI: https://doi.org/10.1007/BF00647439